Enhancer of zeste homolog 2: A potential target for tumor therapy

被引：31
|
作者：
Xiao, Yongtao [1 ]
机构：
[1] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2011年 / 43卷 / 04期
关键词：
Enhancer of zeste homolog 2; H3K27; Methylation; Phosphorylation; Cancer therapy; GROUP PROTEIN EZH2; MALIGNANT MYELOID DISORDERS; H3; LYSINE-27; METHYLATION; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; CRITICAL REGION; GENE; EXPRESSION; MECHANISMS; BLADDER;
D O I：
10.1016/j.biocel.2011.01.005
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Enhancer of zeste homolog 2 (EZH2) is a subunit of the Polycomb-Repressive Complex 2 (PRC2), which catalyses the trimethylation of histone H3 on Lys 27 (H3K27) and involves in genes repression. EZH2 is amplified and overexpressed in a variety of cancers, including prostate and breast cancer. Overexpression of EZH2 has been associated with the invasion and progression of malignant cancers, especially with the progression of prostate cancer. Here, we review the structure and biological function of EZH2, especially focused on its activities in the tumorigenesis. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：474 / 477
页数：4
相关论文
共 50 条
  • [31] Inhibition of enhancer of zeste homolog 2 prevents corneal myofibroblast transformation in vitro
    Liao, Kai
    Cui, Zekai
    Zeng, Yong
    Liu, Jian
    Wang, Yini
    Wang, Zhijie
    Tang, Shibo
    Chen, Jiansu
    EXPERIMENTAL EYE RESEARCH, 2021, 208
  • [32] Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma
    Gayatri Behera
    Suvradeep Mitra
    Tushar S Mishra
    Suvendu Purkait
    Journal of Gastrointestinal Cancer, 2021, 52 : 1029 - 1034
  • [33] Epigenetic Control of Osteoblast Differentiation by Enhancer of Zeste Homolog 2 (EZH2)
    Amel Dudakovic
    Andre J. van Wijnen
    Current Molecular Biology Reports, 2017, 3 (2) : 94 - 106
  • [34] Structural insights into binding of small molecule inhibitors to Enhancer of Zeste Homolog 2
    Marko Kalinić
    Mire Zloh
    Slavica Erić
    Journal of Computer-Aided Molecular Design, 2014, 28 : 1109 - 1128
  • [35] Abundant expression of enhancer of zeste homolog 2 in small cell lung cancer
    Watanabe, Yasutaka
    Koyama, Nobuyuki
    Iwai, Yuki
    Miwa, Chihiro
    Koyama, Shinichiro
    CANCER RESEARCH, 2015, 75
  • [36] HISTONE METHYLTRANSFERASE ENHANCER OF ZESTE HOMOLOG 2 REGULATES SCHWANN CELL DIFFERENTIATION
    Heinen, A.
    Tzekova, N.
    Graffmann, N.
    Torres, K. J.
    Uhrberg, M.
    Hartung, H-P
    Kuery, P.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 (03) : 264 - 265
  • [37] Structural insights into binding of small molecule inhibitors to Enhancer of Zeste Homolog 2
    Kalinic, Marko
    Zloh, Mire
    Eric, Slavica
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2014, 28 (11) : 1109 - 1128
  • [38] Targeting enhancer of zeste homolog 2 protects against acute kidney injury
    X. Zhou
    X. Zang
    Y. Guan
    T. Tolbert
    T. C. Zhao
    G. Bayliss
    S. Zhuang
    Cell Death & Disease, 9
  • [39] Histone methyltransferase enhancer of zeste homolog 2 regulates Schwann cell differentiation
    Heinen, Andre
    Tzekova, Nevena
    Graffmann, Nina
    Torres, Klintsy Julieta
    Uhrberg, Markus
    Hartung, Hans-Peter
    Kuery, Patrick
    GLIA, 2012, 60 (11) : 1696 - 1708
  • [40] Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)
    Xu, Xin
    Chen, Jia
    Wang, Guan
    Zhang, Xiaojuan
    Li, Qiang
    Zhou, Xiaobo
    Guo, Fengying
    Li, Min
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 97
12345